Prostate-specific membrane androgen PET/CT can help clinicians intensify or de-escalate care for men with prostate cancer who ...
The biopsy came back positive. It’s lung cancer.” Countless people in our community hear these words no one ever expects.
The PET tracer [ 89 Zr]Zr-girentuximab targets carbonic anhydrase IX (CAIX), a hypoxia-inducible enzyme that is strongly expressed in clear cell renal cell carcinoma (ccRCC). CAIX expression is highly ...
ZIRCON-X was designed as a post-hoc analysis of imaging data collected in the ZIRCON trial to evaluate how the incorporation of 89 Zr-girentuximab PET imaging could influence clinical management ...
Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...
Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and will never cause harm.
A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.
First results of the PRIMARY2 randomized phase III trial support consideration of PSMA PET/CT in diagnostic work-up ...
United Imaging, a global innovator in AI-powered advanced medical imaging technologies and intelligent healthcare solutions, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results